{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:31:55Z","timestamp":1785807115763,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hubei Provincial Natural Science Foundation of China","award":["2020CFB232"],"award-info":[{"award-number":["2020CFB232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11011-020-00665-5","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T01:55:15Z","timestamp":1610502915000},"page":"463-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Lipid metabolic dysregulation is involved in Parkinson\u2019s disease dementia"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-7861","authenticated-orcid":false,"given":"Mei-Xue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennett SAL (2019) Dysregulated lipid metabolism and its role in \u03b1-Synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13:328","journal-title":"Front Neurosci"},{"key":"665_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli A et al (2013) EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol 20:16\u201334. https:\/\/doi.org\/10.1111\/ene.12022","journal-title":"Eur J Neurol"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11011-020-00541-2","volume":"35","author":"G Chen","year":"2020","unstructured":"Chen G, Wang Y, Li Y, Zhang L, Dong M (2020) A novel hippocampus metabolite signature in diabetes mellitus rat model of diabetic encephalopathy. Metab Brain Dis 35:895\u2013904. https:\/\/doi.org\/10.1007\/s11011-020-00541-2","journal-title":"Metab Brain Dis"},{"key":"665_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBDPsD Collaborators","year":"2018","unstructured":"Collaborators GBDPsD (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"665_CR5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505. https:\/\/doi.org\/10.1093\/brain\/awr031","journal-title":"Brain"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"e0158848","DOI":"10.1371\/journal.pone.0158848","volume":"11","author":"MX Dong","year":"2016","unstructured":"Dong MX et al (2016) Recombinant tissue plasminogen activator induces neurological side effects independent on thrombolysis in mechanical animal models of focal cerebral infarction: a systematic review and meta-analysis. PLoS One 11:e0158848. https:\/\/doi.org\/10.1371\/journal.pone.0158848","journal-title":"PLoS One"},{"key":"665_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnmol.2018.00257","volume":"11","author":"MX Dong","year":"2018","unstructured":"Dong MX et al (2018a) Integrated analysis reveals altered lipid and glucose metabolism and identifies NOTCH2 as a biomarker for Parkinson\u2019s disease related depression. Front Mol Neurosci 11:257. https:\/\/doi.org\/10.3389\/fnmol.2018.00257","journal-title":"Front Mol Neurosci"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuropharm.2017.09.039","volume":"128","author":"MX Dong","year":"2018","unstructured":"Dong MX et al (2018b) Recombinant tissue plasminogen activator induces long-term anxiety-like behaviors via the ERK1\/2-GAD1-GABA cascade in the hippocampus of a rat model. Neuropharmacology 128:119\u2013131. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.039","journal-title":"Neuropharmacology"},{"key":"665_CR9","doi-asserted-by":"publisher","first-page":"e7505","DOI":"10.1097\/MD.0000000000007505","volume":"96","author":"MX Dong","year":"2017","unstructured":"Dong MX, Hu L, Huang YJ, Xu XM, Liu Y, Wei YD (2017a) Cerebrovascular risk factors for patients with cerebral watershed infarction: A case-control study based on computed tomography angiography in a population from Southwest China. Medicine 96:e7505. https:\/\/doi.org\/10.1097\/MD.0000000000007505","journal-title":"Medicine"},{"key":"665_CR10","doi-asserted-by":"publisher","first-page":"1524107","DOI":"10.1155\/2017\/1524107","volume":"2017","author":"MX Dong","year":"2017","unstructured":"Dong MX, Xu XM, Hu L, Liu Y, Huang YJ, Wei YD (2017b) Serum Butyrylcholinesterase activity: a biomarker for Parkinson\u2019s disease and related dementia. Biomed Res Int 2017:1524107. https:\/\/doi.org\/10.1155\/2017\/1524107","journal-title":"Biomed Res Int"},{"key":"665_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","volume":"6","author":"S Fanning","year":"2020","unstructured":"Fanning S, Selkoe D, Dettmer U (2020) Parkinson\u2019s disease: proteinopathy or lipidopathy? NPJ Parkinsons Dis 6:3. https:\/\/doi.org\/10.1038\/s41531-019-0103-7","journal-title":"NPJ Parkinsons Dis"},{"key":"665_CR12","doi-asserted-by":"publisher","unstructured":"Fiandaca M et al (2018) Potential metabolomic linkage in blood between Parkinson\u2019s disease and traumatic brain injury. Metabolites 8. https:\/\/doi.org\/10.3390\/metabo8030050","DOI":"10.3390\/metabo8030050"},{"key":"665_CR13","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/j.1532-5415.2010.03164.x","volume":"58","author":"V Frisardi","year":"2010","unstructured":"Frisardi V, Panza F, Solfrizzi V, Seripa D, Pilotto A (2010) Plasma lipid disturbances and cognitive decline. J Am Geriatr Soc 58:2429\u20132430. https:\/\/doi.org\/10.1111\/j.1532-5415.2010.03164.x","journal-title":"J Am Geriatr Soc"},{"key":"665_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JPD-171103","volume":"7","author":"C Galvagnion","year":"2017","unstructured":"Galvagnion C (2017) The role of lipids interacting with \u03b1-Synuclein in the pathogenesis of Parkinson\u2019s disease. J Parkinsons Dis 7:433\u2013450","journal-title":"J Parkinsons Dis"},{"key":"665_CR15","doi-asserted-by":"publisher","unstructured":"Goldman J, Sieg E (2020) Cognitive impairment and dementia in Parkinson disease clinics. in geriatric medicine 36:365\u2013377. https:\/\/doi.org\/10.1016\/j.cger.2020.01.001","DOI":"10.1016\/j.cger.2020.01.001"},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/mds.27173","volume":"32","author":"W Han","year":"2017","unstructured":"Han W, Sapkota S, Camicioli R, Dixon R, Li L (2017) Profiling novel metabolic biomarkers for Parkinson\u2019s disease using in-depth metabolomic analysis . Mov Disord 32:1720\u20131728. https:\/\/doi.org\/10.1002\/mds.27173","journal-title":"Mov Disord"},{"key":"665_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2020.00080","volume":"13","author":"L Hu","year":"2020","unstructured":"Hu L et al (2020) Integrated metabolomics and proteomics analysis reveals plasma lipid metabolic disturbance in patients with Parkinson\u2019s disease. Front Mol Neurosci 13:80. https:\/\/doi.org\/10.3389\/fnmol.2020.00080","journal-title":"Front Mol Neurosci"},{"key":"665_CR18","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/ene.13013","volume":"23","author":"L Hu","year":"2016","unstructured":"Hu L, Dong MX, Zhao H, Xu GH, Qin XY (2016) Fibulin-5: a novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage European. J Neurol 23:1195\u20131201. https:\/\/doi.org\/10.1111\/ene.13013","journal-title":"J Neurol"},{"key":"665_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000194660","volume":"27","author":"C Huang","year":"2009","unstructured":"Huang C, Dong B, Wu H, Zhang Y, Wu J, Lu Z, Flaherty J (2009) Association of cognitive impairment with serum lipid\/lipoprotein among Chinese nonagenarians and centenarians. Dement Geriatr Cogn 27:111\u2013116. https:\/\/doi.org\/10.1159\/000194660","journal-title":"Dement Geriatr Cogn"},{"key":"665_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"D Irwin","year":"2013","unstructured":"Irwin D, Lee V, Trojanowski J (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci 14:626\u2013636. https:\/\/doi.org\/10.1038\/nrn3549","journal-title":"Nat Rev Neurosci"},{"key":"665_CR21","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1111\/j.1432-1033.2004.04250.x","volume":"271","author":"E Jo","year":"2004","unstructured":"Jo E, Darabie AA, Han K, Tandon A, Fraser PE, McLaurin J (2004) alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis. Eur J Biochem 271:3180\u20133189","journal-title":"Eur J Biochem"},{"key":"665_CR22","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1074\/jbc.M504894200","volume":"280","author":"S Kubo","year":"2005","unstructured":"Kubo S, Nemani VM, Chalkley RJ, Anthony MD, Hattori N, Mizuno Y, Edwards RH, Fortin DL (2005) A combinatorial code for the interaction of alpha-synuclein with membranes. J Biol Chem 280:31664\u201331672","journal-title":"J Biol Chem"},{"key":"665_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cca.2020.08.005","volume":"510","author":"S Kumari","year":"2020","unstructured":"Kumari S et al (2020) Identification of potential urine biomarkers in idiopathic Parkinson\u2019s disease using NMR . Clin Chim Acta 510:442\u2013449. https:\/\/doi.org\/10.1016\/j.cca.2020.08.005","journal-title":"Clin Chim Acta"},{"key":"665_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission . Lancet 396:413\u2013446. https:\/\/doi.org\/10.1016\/s0140-6736(20)30367-6","journal-title":"Lancet"},{"key":"665_CR25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/jnnp.2005.063388","volume":"76","author":"I Masse","year":"2005","unstructured":"Masse I, Bordet R, Deplanque D, Al Khedr A, Richard F, Libersa C, Pasquier F (2005) Lipid lowering agents are associated with a slower cognitive decline in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 76:1624\u20131629. https:\/\/doi.org\/10.1136\/jnnp.2005.063388","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"665_CR26","doi-asserted-by":"publisher","first-page":"e73094","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"M Mielke","year":"2013","unstructured":"Mielke M et al (2013) Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PloS one 8:e73094. https:\/\/doi.org\/10.1371\/journal.pone.0073094","journal-title":"PloS one"},{"key":"665_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41531-020-00121-2","volume":"6","author":"T Phongpreecha","year":"2020","unstructured":"Phongpreecha T et al (2020) Multivariate prediction of dementia in Parkinson\u2019s disease. NPJ Parkinsons Dis 6:20. https:\/\/doi.org\/10.1038\/s41531-020-00121-2","journal-title":"NPJ Parkinsons Dis"},{"key":"665_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-020-00636-w","author":"T Pingale","year":"2020","unstructured":"Pingale T, Gupta G (2020) Current and emerging therapeutic targets for Parkinson\u2019s disease. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-020-00636-w","journal-title":"Metab Brain Dis"},{"key":"665_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.neubiorev.2010.04.010","volume":"34","author":"BG Schreurs","year":"2010","unstructured":"Schreurs BG (2010) The effects of cholesterol on learning and memory. Neurosci Biobehav Rev 34:1366\u20131379. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.04.010","journal-title":"Neurosci Biobehav Rev"},{"key":"665_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuint.2017.12.014","volume":"119","author":"M Suzuki","year":"2018","unstructured":"Suzuki M, Sango K, Wada K, Nagai Y (2018) Pathological role of lipid interaction with \u03b1-synuclein in Parkinson\u2019s disease. Neurochem Int 119:97\u2013106","journal-title":"Neurochem Int"},{"key":"665_CR31","doi-asserted-by":"publisher","unstructured":"Vascellari S et al (2020) Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems 5. https:\/\/doi.org\/10.1128\/mSystems.00561-20","DOI":"10.1128\/mSystems.00561-20"},{"key":"665_CR32","doi-asserted-by":"publisher","unstructured":"Yilmaz A et al (2020) Metabolic profiling of CSF from people suffering from sporadic and LRRK2 Parkinson\u2019s disease: A pilot study. Cells 9. https:\/\/doi.org\/10.3390\/cells9112394","DOI":"10.3390\/cells9112394"},{"key":"665_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ana.410270412","volume":"27","author":"M Zhang","year":"1990","unstructured":"Zhang M et al (1990) The prevalence of dementia and Alzheimer\u2019s disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 27:428\u2013437. https:\/\/doi.org\/10.1002\/ana.410270412","journal-title":"Ann Neurol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00665-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-020-00665-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00665-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T07:40:23Z","timestamp":1612424423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-020-00665-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00665-5","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of the First Affiliated Hospital of Chongqing Medical University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}